We are live on ! Find out more
ACM

Anfield Capital Management Portfolio holdings

AUM $363M
1-Year Est. Return 24.08%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+24.08%
3 Year Est. Return
+65.24%
5 Year Est. Return
+71.54%
10 Year Est. Return
AUM
$216M
AUM Growth
+$11.5M
Cap. Flow
+$9.43M
Cap. Flow %
4.36%
Top 10 Hldgs %
56.33%
Holding
95
New
10
Increased
38
Reduced
11
Closed
27
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HALO icon
76
Halozyme
HALO
$12.2B
-312
Closed -$17.8K
INCY icon
77
Incyte
INCY
$24.4B
-734
Closed -$59K
INMD icon
78
InMode
INMD
$880M
-449
Closed -$16K
IRWD icon
79
Ironwood Pharmaceuticals
IRWD
$714M
-2,433
Closed -$30.1K
IWP icon
80
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
-80,559
Closed -$7.21M
IXJ icon
81
iShares Global Healthcare ETF
IXJ
$4.19B
-28,041
Closed -$2.39M
LH icon
82
Labcorp
LH
$25.9B
-303
Closed -$61.2K
MOS icon
83
The Mosaic Company
MOS
$7.33B
-78,465
Closed -$273K
MRK icon
84
Merck
MRK
$318B
-1,605
Closed -$178K
MRNA icon
85
Moderna
MRNA
$23.6B
-910
Closed -$163K
QURE icon
86
uniQure
QURE
$3.22B
-751
Closed -$17K
RCUS icon
87
Arcus Biosciences
RCUS
$3.64B
-531
Closed -$11K
RDVY icon
88
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
-5,000
Closed -$233K
REGN icon
89
Regeneron Pharmaceuticals
REGN
$80.8B
-228
Closed -$165K
RGNX icon
90
Regenxbio
RGNX
$708M
-640
Closed -$14.5K
VIR icon
91
Vir Biotechnology
VIR
$1.49B
-667
Closed -$16.9K
VRTX icon
92
Vertex Pharmaceuticals
VRTX
$126B
-532
Closed -$154K
SWAV
93
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-185
Closed -$38K
APXH
94
DELISTED
APEX HealthCare ETF
APXH
-63,533
Closed -$564K
HZNP
95
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-705
Closed -$80.2K

Similar funds

Anfield Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Anfield Capital Management held 95 positions worth $216M, up 5.6% from $205M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Anfield Capital Management deployed $9.43M of net new capital in Q1 2023, opening 10 new positions and adding to 38 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 400 Mid Cap ETF: 194,945 shares worth $8.57M.

By sector, the portfolio is most concentrated in Real Estate at 1.8% of assets, down from 1.8% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $2.1M trimmed.

  • Anfield Capital Management's largest Q1 2023 buy was State Street SPDR Portfolio S&P 400 Mid Cap ETF: 194,945 shares worth $8.57M.
  • Anfield Capital Management added most to State Street SPDR Bloomberg High Yield Bond ETF in Q1 2023, an estimated $1.43M increase.
  • Anfield Capital Management's biggest Q1 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $2.1M.
  • Anfield Capital Management fully exited iShares Russell Mid-Cap Growth ETF in Q1 2023, selling an estimated $7.21M.
  • Anfield Capital Management's ten largest holdings make up 56% of its $216M portfolio in Q1 2023.
  • Anfield Capital Management opened 10 new positions and closed 27 in Q1 2023.
  • Anfield Capital Management's portfolio value rose 5.6% quarter-over-quarter to $216M.

Based on Anfield Capital Management's 13F filing for Q1 2023, filed 4 May 2023.